Stock Analysis
- Hong Kong
- /
- Retail Distributors
- /
- SEHK:911
Qianhai Health Holdings Full Year 2023 Earnings: HK$0.031 loss per share (vs HK$0.14 loss in FY 2022)
Qianhai Health Holdings (HKG:911) Full Year 2023 Results
Key Financial Results
- Revenue: HK$961.3m (down 51% from FY 2022).
- Net loss: HK$52.7m (loss narrowed by 77% from FY 2022).
- HK$0.031 loss per share (improved from HK$0.14 loss in FY 2022).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Qianhai Health Holdings shares are up 35% from a week ago.
Risk Analysis
You should learn about the 4 warning signs we've spotted with Qianhai Health Holdings (including 3 which don't sit too well with us).
Valuation is complex, but we're here to simplify it.
Discover if Qianhai Health Holdings might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SEHK:911
Qianhai Health Holdings
An investment holding company, engages in the sale of health-care products and electronic component products in Hong Kong.